Barrier initiated by Leerink Swann at market perform

Barrier Therapeutics Inc. was initiated by Leerink Swann & Co. analyst Gary Nachman with a market perform rating. Barrier, based in Princeton, N.J., is focused on dermatology products. The company markets Solage in the U.S. and Canada and has eight product candidates in its pipeline. Barrier shares Friday lost 13 cents, or 1.35%, to $9.53 on volume of 291,546 shares versus the three-month running average of 239,837.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.